MYOC

myocilin

Basic information

Region (hg38): 1:171635417-171652688

Previous symbols: [ "GLC1A" ]

Links

ENSG00000034971NCBI:4653OMIM:601652HGNC:7610Uniprot:Q99972AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • glaucoma 1, open angle, A (Definitive), mode of inheritance: AD
  • glaucoma 1, open angle, A (Strong), mode of inheritance: AD
  • congenital glaucoma (Supportive), mode of inheritance: AD
  • juvenile open angle glaucoma (Supportive), mode of inheritance: AD
  • glaucoma 1, open angle, A (Definitive), mode of inheritance: AD
  • open-angle glaucoma (Definitive), mode of inheritance: AD
  • juvenile open angle glaucoma (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Glaucoma 1, open angle, AAD/AR/DigenicOphthalmologic; PharmacogenomicEarly diagnosis and treatment may be effective to decrease morbidity and mortality related to vision loss; Agents that may contribute to glaucoma should be avoidedOphthalmologic8513321; 9005853; 9535666; 10330365; 11535458; 11709019; 11774072; 15025728; 15108121; 15733270; 17562996; 17197538; 17499207
Digenic inheritance (with CYP1B1) has been reported

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYOC gene.

  • Open-angle_glaucoma (114 variants)
  • Glaucoma_of_childhood (93 variants)
  • Glaucoma_1,_open_angle,_A (66 variants)
  • Glaucoma_1,_open_angle,_E (56 variants)
  • not_provided (53 variants)
  • Glaucoma (38 variants)
  • Inborn_genetic_diseases (26 variants)
  • MYOC-related_disorder (14 variants)
  • not_specified (9 variants)
  • Primary_open_angle_glaucoma (2 variants)
  • Constitutional_megaloblastic_anemia_with_severe_neurologic_disease (1 variants)
  • RECLASSIFIED_-_MYOC_POLYMORPHISM (1 variants)
  • GLAUCOMA_1,_OPEN_ANGLE,_A,_DIGENIC (1 variants)
  • GLAUCOMA_3,_PRIMARY_CONGENITAL,_A,_DIGENIC (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYOC gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000261.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
30
clinvar
18
clinvar
6
clinvar
54
missense
7
clinvar
21
clinvar
160
clinvar
18
clinvar
1
clinvar
207
nonsense
2
clinvar
13
clinvar
1
clinvar
16
start loss
0
frameshift
14
clinvar
14
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 9 21 218 37 7

Highest pathogenic variant AF is 0.00115863

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYOCprotein_codingprotein_codingENST00000037502 317267
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.63e-120.13512515135941257480.00238
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5202532770.9120.00001583280
Missense in Polyphen6491.1060.702481113
Synonymous-0.09271151141.010.000006521013
Loss of Function0.6381922.20.8540.00000158224

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002700.00270
Ashkenazi Jewish0.000.00
East Asian0.009730.00967
Finnish0.004200.00421
European (Non-Finnish)0.002030.00202
Middle Eastern0.009730.00967
South Asian0.001310.00127
Other0.0008150.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Secreted glycoprotein regulating the activation of different signaling pathways in adjacent cells to control different processes including cell adhesion, cell-matrix adhesion, cytoskeleton organization and cell migration. Promotes substrate adhesion, spreading and formation of focal contacts. Negatively regulates cell-matrix adhesion and stress fiber assembly through Rho protein signal transduction. Modulates the organization of actin cytoskeleton by stimulating the formation of stress fibers through interactions with components of Wnt signaling pathways. Promotes cell migration through activation of PTK2 and the downstream phosphatidylinositol 3-kinase signaling. Plays a role in bone formation and promotes osteoblast differentiation in a dose-dependent manner through mitogen-activated protein kinase signaling. Mediates myelination in the peripheral nervous system through ERBB2/ERBB3 signaling. Plays a role as a regulator of muscle hypertrophy through the components of dystrophin-associated protein complex. Involved in positive regulation of mitochondrial depolarization. Plays a role in neurite outgrowth. May participate in the obstruction of fluid outflow in the trabecular meshwork. {ECO:0000250|UniProtKB:O70624, ECO:0000269|PubMed:17516541, ECO:0000269|PubMed:17984096, ECO:0000269|PubMed:18855004, ECO:0000269|PubMed:19188438, ECO:0000269|PubMed:19959812, ECO:0000269|PubMed:21656515, ECO:0000269|PubMed:23629661, ECO:0000269|PubMed:23897819}.;
Disease
DISEASE: Glaucoma 1, open angle, A (GLC1A) [MIM:137750]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. {ECO:0000269|PubMed:10196380, ECO:0000269|PubMed:10330365, ECO:0000269|PubMed:10340788, ECO:0000269|PubMed:10644174, ECO:0000269|PubMed:10798654, ECO:0000269|PubMed:10819638, ECO:0000269|PubMed:10873982, ECO:0000269|PubMed:10916185, ECO:0000269|PubMed:10980537, ECO:0000269|PubMed:11004290, ECO:0000269|PubMed:11774072, ECO:0000269|PubMed:12189160, ECO:0000269|PubMed:12356829, ECO:0000269|PubMed:12362081, ECO:0000269|PubMed:12442283, ECO:0000269|PubMed:12860809, ECO:0000269|PubMed:12872267, ECO:0000269|PubMed:15025728, ECO:0000269|PubMed:15255110, ECO:0000269|PubMed:15534471, ECO:0000269|PubMed:15795224, ECO:0000269|PubMed:16401791, ECO:0000269|PubMed:17210859, ECO:0000269|PubMed:17499207, ECO:0000269|PubMed:25524706, ECO:0000269|PubMed:9005853, ECO:0000269|PubMed:9328473, ECO:0000269|PubMed:9345106, ECO:0000269|PubMed:9361308, ECO:0000269|PubMed:9490287, ECO:0000269|PubMed:9510647, ECO:0000269|PubMed:9521427, ECO:0000269|PubMed:9535666, ECO:0000269|PubMed:9697688, ECO:0000269|PubMed:9792882, ECO:0000269|PubMed:9863594}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]: An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor. {ECO:0000269|PubMed:15733270}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. MYOC mutations may contribute to GLC3A via digenic inheritance with CYP1B1 and/or another locus associated with the disease (PubMed:15733270). {ECO:0000269|PubMed:15733270}.;

Recessive Scores

pRec
0.410

Intolerance Scores

loftool
0.209
rvis_EVS
-0.13
rvis_percentile_EVS
43.91

Haploinsufficiency Scores

pHI
0.492
hipred
N
hipred_score
0.229
ghis
0.495

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.594

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Myoc
Phenotype
vision/eye phenotype; normal phenotype;

Gene ontology

Biological process
osteoblast differentiation;negative regulation of cell-matrix adhesion;positive regulation of phosphatidylinositol 3-kinase signaling;skeletal muscle hypertrophy;myelination in peripheral nervous system;positive regulation of cell migration;neuron projection development;negative regulation of Rho protein signal transduction;non-canonical Wnt signaling pathway via JNK cascade;ERBB2-ERBB3 signaling pathway;regulation of MAPK cascade;clustering of voltage-gated sodium channels;positive regulation of stress fiber assembly;negative regulation of stress fiber assembly;positive regulation of focal adhesion assembly;positive regulation of protein kinase B signaling;positive regulation of mitochondrial depolarization;bone development;positive regulation of substrate adhesion-dependent cell spreading
Cellular component
extracellular space;mitochondrial outer membrane;mitochondrial inner membrane;mitochondrial intermembrane space;endoplasmic reticulum;rough endoplasmic reticulum;Golgi apparatus;cilium;cytoplasmic vesicle;node of Ranvier;collagen-containing extracellular matrix;extracellular exosome
Molecular function
fibronectin binding;frizzled binding;protein binding;receptor tyrosine kinase binding;myosin light chain binding;metal ion binding